<DOC>
	<DOCNO>NCT02677545</DOCNO>
	<brief_summary>Patients symptomatic asymptomatic carotid stenosis carotid artery stenting plan randomised antiplatelet therapy ticagrelor plus aspirin clopidogrel plus aspirin examine brain MRI stent treatment . The proportion patient new ischaemic lesion MRI treatment compare two group .</brief_summary>
	<brief_title>Ticagrelor Versus Clopidogrel Carotid Artery Stenting</brief_title>
	<detailed_description>Carotid artery stenting ( CAS ) emerge treatment atherosclerotic carotid stenosis . The main adverse event embolic stroke procedure . Current medical management prevent peri-procedural embolisation consist dual antiplatelet therapy clopidogrel aspirin . Ticagrelor , novel reversible inhibitor platelet adenosine diphosphate receptor P2Y12 , superior clopidogrel , add-on therapy aspirin , prevent stent thrombosis , cardiovascular outcome event , death patient undergo coronary artery stenting , without cause increase major bleed event . This study aim test hypothesis ticagrelor superior clopidogrel add-on aspirin prevent cerebral embolism CAS procedure .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Carotid Stenosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Written inform consent document signature patient ; Men woman ≥40 year age ; Moderate ( 5069 % narrow artery accord measure method use NASCET trial64 ) severe ( 7099 % ) stenosis extracranial internal carotid artery cause atherosclerosis ; Symptomatic carotid stenosis ( transient permanent symptom cause focal ischaemia vascular territory supply carotid artery past 180 day , include ischaemic stroke , transient ischemic attack ( TIA ) , amaurosis fugax ischaemic retinal infarct ) , long patient clinically stable independent ( mRS ≤2 ) time randomisation ; asymptomatic carotid stenosis ( ischaemic symptom past 180 day ) ; Stenosis amenable treatment CAS accord routine clinical workup ( degree stenosis suitability vascular anatomy CAS must demonstrate either consistent finding two follow noninvasive image modality : duplex ultrasound , magnetic resonance angiography , computer tomography angiography ; intraarterial digital subtraction angiography ) ; CAS schedule take place within 13 day randomisation . Inability unwillingness patient understand and/or comply study procedure and/or followup , e.g . due language problem , psychological disorder , dementia , etc . ; Women pregnant breast feeding , intend become pregnant course study . Women childbearing age must take pregnancy test eligible study ; Lack safe contraception , define : Female Participants childbearing potential , use willing continue use medically reliable method contraception entire study duration , oral , injectable , implantable contraceptive , intrauterine contraceptive device , use method consider sufficiently reliable Investigator individual case . Female Participants surgically sterilise / hysterectomised postmenopausal longer 2 year consider child bear potential ; Acute ischaemic stroke symptom onset previous 24 hour randomisation ; Fresh thrombus relevant carotid artery ; Patient clinically unstable time randomisation ( include worsen NIH Stroke Scale &gt; 2 point previous 24 hour ) ; Patient dependent others function daily live time randomisation ( mRS &gt; 2 ) ; Patients know bleed diathesis coagulation disorder ( e.g. , thromboticthrombocytopenic purpura ) ; Any active pathological bleed ; Severe thrombocytopenia ( platelet count &lt; 50'000/uL ) ; History previous symptomatic intracranial haemorrhage time ( asymptomatic microbleeds qualify ) History gastrointestinal bleed within past 6 month ; Any contraindication noncontrast MRI , include limited : cardiac pacemaker incompatible MRI ; metal implant incompatible MRI ; claustrophobia ) ; Contraindications ticagrelor , clopidogrel , acetylsalicylic acid ( ASA ) , excipients , include know hypersensitivity allergy ; Increased risk bradycardic event ( e.g. , patient without pacemaker sick sinus syndrome , 2nd 3rd degree atrioventricular ( AV ) block , history bradycardiarelated syncope ; Need medication permit treatment period : Antithrombotic therapy Study Medication permit concomitant medication ( see section 8.7 ) include : Antiplatelet therapy ( ASA 100 mg daily ) , e.g . : openlabel clopidogrel ticagrelor ; GPIIb/GPIIIa inhibitor , ticlopidine , prasugrel , dipyridamole , ozagrel , cilostazol ; Therapeuticdose anticoagulation ( unfractioned heparin start CAS procedure ) , e.g . : phenprocoumon , warfarin , oral thrombin factor Xa inhibitor , bivalirudin , hirudin , argatroban , unfractionated low molecular weight heparin ; Receipt intravenous intraarterial thrombolysis mechanical thrombectomy within 24 hour prior randomisation . If patient require intravenous intraarterial thrombolytic therapy treatment period , Study Medication must discontinue least 24 hour ; Strong cytochrome P450 3A ( CYP3A ) inhibitor lead substantial increase ticagrelor plasma level : ketoconazole , itraconazole , voriconazole , telithromycin , clarithromycin ( erythromycin azithromycin ) , nefazadone , ritonavir , saquinavir , nelfinavir , indinavir , atazanavir ; consumption 1 litre grapefruit juice daily ; Strong CYP3A inducer lead substantial decrease ticagrelor plasma level : rifampicin , rifabutin , phenytoin , carbamazepine , phenobarbital ; CYP3A substrates narrow therapeutic index may substantially increase coadministration ticagrelor : cyclosporine , quinidine , simvastatin dos &gt; 40 mg daily lovastatin dose &gt; 40 mg daily . ( Coadministration ticagrelor simvastatin increase simvastatin Cmax 81 % area curve ( AUC ) 56 % increase simvastatin acid Cmax 64 % AUC 52 % individual increase equal 2 3fold . Ticagrelor may similar effect lovastatin , expect clinically meaningful effect statins include atorvastatin rosuvastatin ) ; Anticipated requirement longterm ( &gt; 7 day ) nonsteroidal antiinflammatory drug ( NSAIDs ; shortterm treatment NSAIDs 7 day allow treatment period investigator 's discretion ) ; Need invasive procedure ( surgery intervention ) index CAS procedure patient randomise , require halt Study Medication within next 30 day randomisation ; History major surgery within past 30 day ; Moderate severe hepatic impairment ; Renal impairment require dialysis ; Known suspect noncompliance , drug alcohol abuse ; Previous enrolment present study ; Participation another study investigational drug within 30 day precede present study ; Patients incapable judgment patient tutelage ; Enrolment Investigator , his/her family member , employee dependent person ;</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>